The prodigiosins, proapoptotic drugs with anticancer properties

This publication has 58 references indexed in Scilit:

• Copper and carcinogenesis
  Critical Reviews in Oncology/Hematology, 2002
• Prodigiosin from the supernatant of Serratia marcescens induces apoptosis in haematopoietic cancer cell lines
  British Journal of Pharmacology, 2000
• Cycloprodigiosin hydrochloride, a H + /Cl − symporter, induces apoptosis in human breast cancer cell lines
  Zeitschrift für Krebsforschung und Klinische Onkologie, 2000
• In vivorapid reduction of alloantigen-activated CD8⁺mature cytotoxic T cells by inhibitors of acidification of intracellular organelles, prodigiosin 25-C and concanamycin B
  Immunology, 2000
• Cycloprodigiosin hydrochloride, a new H+/Cl− symporter, induces apoptosis in human and rat hepatocellular cancer cell lines in vitro and inhibits the growth of hepatocellular carcinoma xenografts in nude mice
  Hepatology, 1999
• Disruption of p53 in human cancer cells alters the responses to therapeutic agents
  Journal of Clinical Investigation, 1999
• A Possible Immunosuppressant, Cycloprodigiosin Hydrochloride, Obtained fromPseudoalteromonas denitrificans
  Biochemical and Biophysical Research Communications, 1997
• Short synthesis of undecylprodigiosine. A new route to 2,2’-bipyrrolyl-pyrromethene systems
  Synlett, 1996
• Prodigiosin 25‐C uncouples vacuolar type H⁺‐ATPase, inhibits vacuolar acidification and affects glycoprotein processing
  FEBS Letters, 1995
• Inhibition of radiation-induced apoptosis in vitro by tumor promoters
  Biochemical and Biophysical Research Communications, 1988